{
    "id": "624f2355e764a5320400000b",
    "question": "Is the 22-item sino-nasal outcome test (SNOT-22) a widely used measure for Health-Related Quality-of-Life (HRQOL) associated with chronic rhinosinusitis (CRS)?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, let's break down the process into steps: 1. Identify the SNOT-22: The Sino-Nasal Outcome Test-22 (SNOT-22) is a questionnaire used to measure the impact of nasal and sinus symptoms on a patient's quality of life. It assesses symptoms, functional impact, and the impact of symptoms on daily activities. 2. Understand the scope of the SNOT-22: The SNOT-22 specifically focuses on the symptoms and impact of chronic rhinosinusitis (CRS), which is a common condition characterized by persistent inflammation of the nasal passages and sinuses. 3. Evaluate the use of the SNOT-22 in CRS: The SNOT-22 is widely used in clinical practice and research to assess the severity and impact of CRS on patients' quality of life. It provides a comprehensive measure of symptoms, functional impairment, and the impact of CRS on daily activities. 4. Compare with other HRQOL measures: The SNOT-22 is often used in conjunction with other HRQOL measures, such as the Sinusitis Health Questionnaire (SHQ) and the SF-36. However, the SNOT-22 is specifically tailored to CRS and is considered a valuable tool in assessing the disease's impact on patients' quality of life. 5. Conclusion: Based on the above steps, the SNOT-22 is indeed a widely used measure for assessing Health-Related Quality-of-Life (HRQOL) associated with chronic rhinosinusitis (CRS). \", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 43.40758490562439
}